A randomized study of conventional chemotherapy +/- uproleselan in older adults with Acute Myeloid Leukemia eceiving intensive induction chemotherapy (Alliance A041701)
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Geoffrey Uy, Jun Yin, Shira Dinner, Meagan Jacoby, Daniel Deangelo, Jane Liesveld, Jonathan Kolitz, Adam Asch, Olatoyosi Odenike, Oudom Kour, Korrie Skogen, Ken Byrd, Richard Little, Steven Gore, Andrew Carroll, Krzysztof Mrózek, John Byrd, Ann-Kathrin Eisfeld, Anthony Jaslowski, Harry Erba, Mark Litzow, Wendy Stock, Richard Stone
Institutions: Washington University in St. Louis, Northwestern University, University of Rochester, Northwell Health, University of Oklahoma Health Sciences Center, University of Chicago, The University of Kansas Cancer Center, National Cancer Institute, University of Alabama at Birmingham, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, University of Cincinnati, University of Cincinnati Medical Center, Duke University, Mayo Clinic
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7108481167
Cites:
Cited by:
Related to:
